1. The Board has appointed Mr. Rajender Parsad (DIN: 10871533) as an Additional & Non- Executive Director of the Company w.e.f 24rd January, 2026 a brief profile pursuant to SEBI Circular ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare's board, at a meeting held on 24 January 2026, appointed Mr. Rajender Parsad (DIN: 10871533) as an Additional & Non-Executive Director of the company. In the same meeting, the board accepted the resignation of Ms. Babita (DIN: 09064124), a Non-Executive & Independent Director, effective 24 January 2026, citing personal and unavoidable reasons. The company confirmed Mr. Parsad is not related to any existing directors or key managerial personnel and is not debarred by SEBI or any other authority. Ms. Babita also confirmed there are no other material reasons for her resignation beyond those stated.
This is a routine board composition change with one new non-executive director replacing one resigning independent director. No material governance concerns are flagged, and net board strength remains unchanged, suggesting minimal impact on shareholders or stock price.